Stryker Corporation
SYK
Rangering i aksjer
#191
Stryker Corporation functions as a prominent medical technology enterprise,... Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
Aksjekurs
$304.72
Sist synkronisert: 2026-10-20
Markedsverdi
$116.88B
Endring (1 dag)
1.96%
Endring (1 år)
-19.76%
Land
US
Handel Stryker Corporation (SYK)
Kategori
Healthcare
P/E-forhold for Stryker Corporation (SYK)
P/E-forhold per October 2026 TTM: 28.94
Ifølge Stryker Corporation sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 28.94. Ved slutten av 2024 hadde selskapet en P/E på 45.83.
P/E-forholdshistorikk for Stryker Corporation fra 2000 til 2026
P/E-forhold ved slutten av hvert år
| År | P/E-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 28.94 | -30.05% |
| 2025 | 41.38 | -9.71% |
| 2024 | 45.83 | 27.61% |
| 2023 | 35.92 | -8.41% |
| 2022 | 39.21 | -22.44% |
| 2021 | 50.56 | -12.14% |
| 2020 | 57.54 | 52.66% |
| 2019 | 37.69 | 128.39% |
| 2018 | 16.50 | -70.93% |
| 2017 | 56.77 | 108.63% |
| 2016 | 27.21 | 11.88% |
| 2015 | 24.32 | -64.92% |
| 2014 | 69.33 | 145.16% |
| 2013 | 28.28 | 75.92% |
| 2012 | 16.07 | 12.53% |
| 2011 | 14.28 | -14.55% |
| 2010 | 16.72 | -7.52% |
| 2009 | 18.08 | 27.26% |
| 2008 | 14.20 | -52.79% |
| 2007 | 30.09 | 4.28% |
| 2006 | 28.85 | 8.62% |
| 2005 | 26.56 | -36.09% |
| 2004 | 41.57 | 6.61% |
| 2003 | 38.99 | -3.57% |
| 2002 | 40.43 | -4.42% |
| 2001 | 42.30 | -5.53% |
| 2000 | 44.78 | 0.00% |
P/E-forhold for lignende selskaper eller konkurrenter
| Selskap | P/E-forhold | Forskjell i P/E-forhold | Land |
|---|---|---|---|
| 33.11 | 14.39% |
US
|
|
| 21.39 | -26.11% |
IE
|
|
| 17.34 | -40.10% |
US
|
|
| - | - |
DE
|
|
| 49.68 | 71.65% |
US
|
Hvordan lese en P/E-ratio?
Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.
Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.
Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.